Moreover, simultaneous exposure of either AS or HFrEF cardiomyocytes to semaglutide plus the GLP‐1 receptor antagonist Ex‐9–39 prevented the inhibitory effect of semaglutide on late INa. Here, GLP1R is linked to aortic stenosis.